MY138085A - Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them - Google Patents
Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including themInfo
- Publication number
- MY138085A MY138085A MYPI20033346A MYPI20033346A MY138085A MY 138085 A MY138085 A MY 138085A MY PI20033346 A MYPI20033346 A MY PI20033346A MY PI20033346 A MYPI20033346 A MY PI20033346A MY 138085 A MY138085 A MY 138085A
- Authority
- MY
- Malaysia
- Prior art keywords
- alkyl
- aryl
- heteroaryl
- medicaments
- pharmaceutical compositions
- Prior art date
Links
- YDTDKKULPWTHRV-UHFFFAOYSA-N 1H-indazol-3-amine Chemical class C1=CC=C2C(N)=NNC2=C1 YDTDKKULPWTHRV-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical class F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 1
- -1 NR1 RADICAL Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
THE PRESENT INVENTION RELATES TO NOVEL DERIVATIVES OF GENERAL FORMULA (I)(I)IN WHICHR3 IS A (1-6C) ALKYL, ARYL, ARYL(1-6C) ALKYL, HETEROARYL, HETEROARYL (1-6C) ALKYL,ARYL OR HETEROARYL FUSED TO A (1-10C) CYCLOALKYL, HETEROCYCLE, HETEROCYCLOALKYL, CYCLOALKYL, ADAMANTYL, POLYCYCLOALKYL, ALKENYL, ALKYNYL, CONR1 R2, COOR1, SO2 R1, C(=NH) R1 OR C(=NH)NR1 RADICAL;R5 , R6 AND R7 ARE, INDEPENDENTLY OF ONE ANOTHER, CHOSEN FROM THE FOLLOWING RADICALS: HALOGEN, CN,NO2,NH2, OH, OR8, COOH, C(O)OR8, -O-C(O)R8, NR8 R9, NHC 9O) R8, C(O)NR8 R9, NHC (S) R8, C(S)NR8 R9, SR8, S(O) R8, SO2 R8, NHSO2 R8, SO2 NR8 R9, -O-SO2 R8, -SO2-O-R8, TRIFLUOROMETHYL, TRIFULOROMETHOXY, (1-6C) ALKYL, (1-6C) ALKOXY, ARYL, ARYL (1-6C) ALKYL, HETEROARYL, HETEROARYL (1-6C) ALKYL,HETEROCYCLE, CYCLOALKYL, ALKENYL, ALKYNYL, ADAMANTYL OR POLYCYCLOALKYL.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0215720A FR2848554A1 (en) | 2002-12-12 | 2002-12-12 | New aminoindazole derivatives are kinase inhibitors, useful in the treatment of neurodegenerative diseases, obesity, metabolic disorders, diabetes, hypertension, polycystic ovarian syndrome, cancers and other disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY138085A true MY138085A (en) | 2009-04-30 |
Family
ID=32338720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20033346A MY138085A (en) | 2002-12-12 | 2003-09-04 | Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JP4764168B2 (en) |
| CN (2) | CN101979382A (en) |
| AR (1) | AR041132A1 (en) |
| AT (1) | ATE520399T1 (en) |
| FR (1) | FR2848554A1 (en) |
| ME (1) | MEP25308A (en) |
| MY (1) | MY138085A (en) |
| PE (2) | PE20091629A1 (en) |
| RS (1) | RS20050421A (en) |
| TW (1) | TWI345561B (en) |
| ZA (1) | ZA200504681B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007002717A1 (en) | 2007-01-18 | 2008-07-24 | Merck Patent Gmbh | Heterocyclic indazole derivatives |
| DE102007022565A1 (en) | 2007-05-14 | 2008-11-20 | Merck Patent Gmbh | Heterocyclic indazole derivatives |
| UY32464A (en) * | 2009-02-26 | 2010-09-30 | Glaxo Group Ltd | NEW INDAZOL COMPOUNDS |
| AU2016281225B2 (en) * | 2015-06-15 | 2020-10-15 | Ube Corporation | Substituted dihydropyrrolopyrazole derivative |
| CN115260165B (en) * | 2021-04-29 | 2024-08-06 | 中国科学院上海药物研究所 | Benzo nitrogen-containing five-membered heterocyclic compound and synthesis and application thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS51143010A (en) * | 1975-06-04 | 1976-12-09 | Kao Corp | Stable bleaching detergent composition |
| AU2001290912A1 (en) * | 2000-09-15 | 2002-03-26 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| US6593349B2 (en) * | 2001-03-19 | 2003-07-15 | Icagen, Inc. | Bisarylamines as potassium channel openers |
| KR20040047869A (en) * | 2001-09-26 | 2004-06-05 | 파마시아 이탈리아 에스.피.에이. | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| FR2836915B1 (en) * | 2002-03-11 | 2008-01-11 | Aventis Pharma Sa | AMINOINDAZOLE DERIVATIVES, PREPARATION METHOD AND INTERMEDIATES THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |
| PL374946A1 (en) * | 2002-09-05 | 2005-11-14 | Aventis Pharma S.A. | Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
-
2002
- 2002-12-12 FR FR0215720A patent/FR2848554A1/en active Pending
-
2003
- 2003-09-01 PE PE2009001071A patent/PE20091629A1/en not_active Application Discontinuation
- 2003-09-01 PE PE2003000886A patent/PE20040996A1/en not_active Application Discontinuation
- 2003-09-03 JP JP2005512867A patent/JP4764168B2/en not_active Expired - Fee Related
- 2003-09-03 RS YUP-2005/0421A patent/RS20050421A/en unknown
- 2003-09-03 AT AT03769560T patent/ATE520399T1/en not_active IP Right Cessation
- 2003-09-03 AR ARP030103187A patent/AR041132A1/en unknown
- 2003-09-03 ME MEP-253/08A patent/MEP25308A/en unknown
- 2003-09-03 CN CN2010105043043A patent/CN101979382A/en active Pending
- 2003-09-03 CN CNA038256169A patent/CN1713909A/en active Pending
- 2003-09-04 MY MYPI20033346A patent/MY138085A/en unknown
- 2003-09-04 TW TW092124409A patent/TWI345561B/en not_active IP Right Cessation
-
2005
- 2005-06-08 ZA ZA200504681A patent/ZA200504681B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200504681B (en) | 2006-08-30 |
| JP2006516266A (en) | 2006-06-29 |
| MEP25308A (en) | 2010-06-10 |
| RS20050421A (en) | 2007-08-03 |
| PE20040996A1 (en) | 2005-01-28 |
| TWI345561B (en) | 2011-07-21 |
| CN101979382A (en) | 2011-02-23 |
| AR041132A1 (en) | 2005-05-04 |
| ATE520399T1 (en) | 2011-09-15 |
| PE20091629A1 (en) | 2009-11-16 |
| JP4764168B2 (en) | 2011-08-31 |
| CN1713909A (en) | 2005-12-28 |
| TW200422293A (en) | 2004-11-01 |
| FR2848554A1 (en) | 2004-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY138269A (en) | Aminoindazole derivatives, preparation process and intermediates of this process as medicinal products, and pharmaceutical compositions containing them | |
| BR0314098A (en) | Aminoindazole derivatives as medicines and pharmaceutical compositions containing them | |
| AR053405A1 (en) | SUBSTITUTED UREA DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOPATIAS | |
| CY1111075T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING THE PRODUCTS OF 3-AMINO-AZETIDINE, THEIR NEW PRODUCTS, AND THEIR PREPARATION | |
| PL412704A1 (en) | Derivatives of phosphonooxyquinazoline their compositions and pharmaceutical application | |
| HUP0301113A2 (en) | Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors, pharmaceutical compositions containing them and their use | |
| HUP0401889A2 (en) | 1,8-naphthyridine derivatives as antidiabetics and pharmaceutical compositions containing them | |
| HUP0302485A2 (en) | Arylmethylamine derivatives for use as tryptase inhibitors and pharmaceutical compositions containing them | |
| HUP0300203A2 (en) | Novel cyclic amide derivatives, and pharmaceutical compositions containing same | |
| EA200600364A1 (en) | DERIVATIVES (TIO) OF CARBAMOILCYCLOGEXANE AS ANTAGONISTS D / D RECEPTOR | |
| DE60010076D1 (en) | CHINOLINE DERIVATIVES AS AN ANTIBACTERIAL AGENTS | |
| EA200600892A1 (en) | NEW QUINOLINE DERIVATIVES | |
| NO20060973L (en) | Pyridyl derivatives and their use as tempeutic agents | |
| SE0202133D0 (en) | Novel compounds | |
| NO20060665L (en) | N-substituted pyrazolyl-amidyl-benzimidazolyl C-kit inhibitors | |
| WO2004018475A3 (en) | Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents | |
| HUP0002353A2 (en) | 1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phoshodiesterase iv inhibitory activity and pharmaceutical compositions containing them | |
| DE602007005811D1 (en) | 6-SUBSTITUTED ISOCHINOLINE DERIVATIVES AS ROCK-1 INHIBITORS | |
| RU2009144538A (en) | NEW CYCLIC PEPTIDE COMPOUNDS | |
| BRPI0307123B8 (en) | piperidine derivatives | |
| DE69924292D1 (en) | PYRAZOL COMPOUNDS AND ITS USE | |
| MY139612A (en) | Benzoxazine derivatives as 5-th6 modulators and uses thereof | |
| IL180495A (en) | Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors | |
| EA200700901A1 (en) | DERIVATIVES 2-AMIDO-4-PHENYL THIAZOLE, THEIR OBTAINING AND USE IN THERAPY | |
| RU2009102270A (en) | THIAZOLYL UREA DERIVATIVES AS PHOSPHATIDYLINOSYTOL-3-KINASE INHIBITORS |